Serum Mac-2 binding protein glycosylation isomer as a biomarker for metabolic dysfunction associated steatotic liver disease
Abstract Background Nonalcoholic fatty liver disease (NAFLD), now recently termed metabolic dysfunction-associated steatotic liver disease (MASLD), is the most rapidly increasing global contributor to the burden of complications in chronic liver disease (CLD) patients such as liver cirrhosis and hep...
Saved in:
| Main Authors: | Ahmed M. F. Mansour, Ehab Nashaat, Asmaa Gouda Seliem Hassan Mohamed, Ahmed Mohamed ElGhandour |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | Egyptian Liver Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43066-025-00419-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD
by: Prooksa Ananchuensook, et al.
Published: (2025-02-01) -
Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy
by: Pei-Chang Lee, et al.
Published: (2025-09-01) -
Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-01-01) -
Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study
by: Yueqiu Wang, et al.
Published: (2025-12-01) -
A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
by: Zülal İstemihan, et al.
Published: (2025-07-01)